Author

Fariborz Mansour-Ghanaei

Gastrointestinal and liver diseases research center(GLDRC), Guilan University of Medical Sciences - Cited by 12,936

Biography

Dr Fariborz Mansour-Ghanaei is Professor of Gastroenterology & Hepatology at Guilan University of MedicalSciences, Iran. Dr Fariborz Mansour-Ghanaei has over 20 peer reviewed publications. Dr Fariborz Mansour-Ghanaei research interests include Clinical pathology, Medicine, Cancer Imaging, Gastroenterology & Hepatology
Title
Cited by
Year
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...The Lancet 400 (10352), 563-591, 2022202
169
2022
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ...The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022202
123
2022
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Global, regional, and national burden of colorectal cancer and its risk factors, 10–2019: a systematic analysis for the Global Burden of Disease Study 2019R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ...The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022202
99
2022
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
S Mobarak, M Salasi, A Hormati, J Khodadadi, M Ziaee, F Abedi, ...Journal of Antimicrobial Chemotherapy 77 (3), 758-766, 2022202
18
2022
The common variant of rs6214 in insulin like growth factor 1 (IGF1) gene: a potential protective factor for non-alcoholic fatty liver disease
M Sabzikarian, T Mahmoudi, SP Tabaeian, G Rezamand, A Asadi, ...Archives of Physiology and Biochemistry 129 (1), 10-15, 2023202
11
2023
Prevalence and predictors of low back pain among the Iranian population: Results from the Persian cohort study
M Ghafouri, A Teymourzadeh, A Nakhostin-Ansari, SG Sepanlou, ...Annals of Medicine and Surgery 74, 103243, 2022202
11
2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
M Zamani, H Poustchi, Z Mohammadi, S Dalvand, M Sharafkhah, ...BMC public health 22 (1), 1031, 2022202
8
2022
Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm
T Zeinali, N Faraji, F Joukar, MK Mirzaei, HK Jalali, M Shenagari, ...Microbial Pathogenesis, 10504, 2022202
7
2022
Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study
S Sepanlou, F Najafi, H Poustchi, M Parsaeian, A Ahmadi, M Somi, ...Scientific reports 12 (1), 4057, 2022202
3
2022
OLGA-and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications
F Mansour-Ghanaei, F Joukar, S Yeganeh, M Sadeghi, A Daryakar, ...The Turkish journal of gastroenterology 33 (), 95, 0
2
2022
Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study
M Amini, M Moradinazar, F Rajati, M Soofi, SG Sepanlou, H Poustchi, ...BMC public health (1), 1-11, 0
2
2022
Prevalence and determinants of anemia among Iranian population aged≥ 35 years: A PERSIAN cohort–based cross-sectional study
M Zamani, H Poustchi, A Shayanrad, F Pourfarzi, M Farjam, K Noemani, ...PloS one 17 (), e063795, 0
2
2022
Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases
B Saberzadeh-Ardestani, A Anushiravani, F Mansour-Ghanaei, H Fakheri, ...Inflammatory bowel diseases 28 (7), 004-0, 2022202
1
2022
The seroprevalence of celiac disease in patients with symptoms of irritable bowel syndrome: A cross-sectional study in the north of Iran
F Joukar, S Yeganeh, A Shafaghi, MR Mahjoub-Jalali, S Hassanipour, ...Human Antibodies 30 (2), 97-03, 2022202
1
2022
Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized …
S Akbari, MH Sohouli, S Ebrahimzadeh, FM Ghanaei, AF Hosseini, ...Phytotherapy Research 36 (5), 286-296, 2022202
1
2022
Liver Abscess due to Fasciola hepatica: A Case Report of the North of Iran
S Matin, F Joukar, S Yeganeh, A Daryakar, F Mansour-GhanaeiCase Reports in Infectious Diseases 2022, 2022202
1
2022
Symptomatic reinfection with COVID-19: A case-report study in Iran
Symptomatic reinfection with COVID-9: A case-report study in IranTY Kalurazi, E Amini-Salehi, S Rahimi-Shamami, R Poursmail, F Joukar, ...Journal of Current Biomedical Reports 3 (2), 98-02, 2022202
1
2022
Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis
E Amini-Salehi, S Hassanipour, F Joukar, AA Daryagasht, MJ Khosousi, ...Hepatitis Monthly 23 (), 2023202
1
2023
The association between age at first pregnancy and number of deliveries with metabolic syndrome and its components: Results from Persian Guilan Cohort Study (PGCS)
M Naghipour, F Joukar, E Amini Salehi, S Hassanipour, ...The Iranian Journal of Obstetrics, Gynecology and Infertility 25 (6), -, 2022202
1
2022
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial
F Mansour-Ghanaei, B Masihipour, M Fathalipour, S Hassanipour, ...Evidence-Based Complementary and Alternative Medicine 2022, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=1U5Sdv0AAAAJ&hl=en

Cited by
Citations 12936
h-index 42
i10-index 140
Recommended Journals
Open Access Journals